Article

Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients with anti-HBV treatment using thymosin a1 combined with entecavir

2020-11-01

Abstract excerpt

For hepatitis B antiviral treatment, there has been no comprehensive method yet. Interferon has poor antiviral efficacy, while nucleoside drugs have long course of treatment and high relapse rate. To improve the anti-HBV curative effect, treatment methods such as thymosin combined with entecavir have become a focus of clinical investigation. To explore potential mechanism of the combination therapy, based on previ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b1ffd06a-5135-58c9-965e-06a7c3124e98
DOI: 10.1101/2020.10.31.363127

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients with anti-HBV treatment using thymosin a1 combined with entecavirDOI 10.1101/2020.10.31.363127Read

An Immune Epigenetic Insight to COVID-19 InfectionSemantic proximity Read

Recent advances in different interactions between toll-like receptors and hepatitis B infection: a reviewSemantic proximity Read

Epstein-Barr virus suppresses N6-methyladenosine modification of TLR9 to promote immune evasionSemantic proximity Read

Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylationSemantic proximity Read

Protein Post‐Translational Modification‐Mediated Control of Type I Interferon Cascade SignalingSemantic proximity Read

Role of epigenetic modification in interferon treatment of hepatitis B virus infectionSemantic proximity Read

Interferon Regulatory Factor 9 Structure and RegulationSemantic proximity Read

Jack of all trades: thymosin α1 and its pleiotropySemantic proximity Read

Influenza A Virus and Acetylation: The Picture Is Becoming ClearerSemantic proximity Read

CXCL9 and CXCL13 as Predictive Biomarkers for Autoimmune-like Phenotype in Chronic Hepatitis C: Evidence for Viral-Induced Autoimmune Hepatitis TransitionSemantic proximity Read

The effect of immunomodulator thymosin α1 on the expression of TNBC PD-L1 through Wnt/β- catenin signaling pathwaySemantic proximity Read

A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.Semantic proximity Read